Compare EHang Holdings Ltd - ADR (EH) vs Johnson & Johnson (JNJ) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
EHang Holdings Ltd - ADR vs Johnson & Johnson — how do they compare? EHang Holdings Ltd - ADR trades at $4.17 (market cap $309.45M), while Johnson & Johnson trades at $260.02 (market cap $618.09B). The key difference: Johnson & Johnson is far larger — about 1997.4× EHang Holdings Ltd - ADR's market cap, and Johnson & Johnson pays a 2.09% dividend while EHang Holdings Ltd - ADR pays none. Which is the better fit depends on your goals — on Pluang, investors hold EHang Holdings Ltd - ADR for 47 Days and Johnson & Johnson for 129 Days on average.
| EH | JNJ | |
|---|---|---|
Market Cap | $309.45M | $618.09B |
Volume | 765,799 | 6,050,983 |
Sector | Industrials | Health |
52-Week High | $18.94 | $278.43 |
52-Week Low | $4.03 | $186.00 |
Typical Hold Time | 47 Days | 129 Days |
Enterprise Value | $261.14M | $646.37B |
Dividend Yield | — | 2.09% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
EHang Holdings Limited (EH) trades at $4.14, showing no recent price movement. The stock is technically bearish with moving averages signaling a downtrend. Fundamentally, the company reported a net loss of $275.98 million on $417.98 million revenue in 2025, with negative profit margins and returns. Recent news includes expansion of its Global Fast Track Program to Vietnam but also multiple law firm investigations into investor claims.
The outlook remains challenging with persistent losses and regulatory scrutiny. Investment opportunities hinge on successful commercialization of eVTOL technology, but risks include high cash burn, negative earnings, and legal uncertainties. Analyst consensus is mixed with 20% buy, 40% hold, and 40% sell ratings, reflecting cautious sentiment.
Johnson & Johnson (JNJ) trades at $259.62, up 0.45% with a bearish technical signal despite recent earnings beats. The stock shows strong fundamentals with 21.48% net margin and 25.74% ROE, though valuation ratios appear elevated with P/E at 29.75. Recent news highlights growth in the Innovative Medicine segment and positive analyst coverage with 52.5% buy ratings.
JNJ offers stable dividend income and pharmaceutical innovation upside, but faces patent cliff risks and increasing debt-to-asset ratio (24.06% in 2025). Analyst consensus target of $286.53 suggests 10% upside potential, though technical resistance at $260 may limit near-term gains.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About EHang Holdings Ltd - ADR
EHang Holdings Ltd is an autonomous aerial vehicle (AAV) technology platform company. It focuses on making safe, autonomous and eco-friendly air mobility accessible to everyone. EHang provides customers in various industries with AAV products and commercial solutions: air mobility (including passenger transportation and logistics), smart city management and aerial media solutions. As the forerunner of cutting-edge AAV technologies and commercial solutions in the global Urban Air Mobility industry, it continues to explore the boundaries of the sky to make flying technologies benefit life in smart cities.
Read more on EH →About Johnson & Johnson
Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.
Read more on JNJ →
